Tumor Ablation Market By Technology, Treatment And Application- Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 190 Category: Healthcare IT Report Code : HC06854
Industry Outlook and Trend Analysis
The Tumor Ablation Market was worth USD 0.28 billion in 2017 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period. Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.
Technology Outlook and Trend Analysis
Radiofrequency tumor ablation technology held considerable share in 2017. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.
Treatment Outlook and Trend Analysis
Surgical ablation fragment held significant share of 42.1% of every 2017. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.
Application Outlook and Trend Analysis
Liver cancer represented biggest shares in 2017. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).
Regional Outlook and Trend Analysis
North America ruled the general tumor ablation market with more than 32.0% share in 2017. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.
Competitive Insights
The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.
The Tumor Ablation Market is segmented as follows-
By Technology:
- Microwave ablation
- Cryoablation
- Radiofrequency ablation
- Other ablation technologies
By Treatment:
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous tumor ablation
By Application:
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Tumor Ablation Market, By Technology, Estimates and Forecast, 2014-2023($Billion)
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
· Tumor Ablation Market, By Treatment, Estimates and Forecast, 2014-2023($Billion)
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous tumor ablation
· Tumor Ablation Market, By Application, Estimates and Forecast, 2014-2023($Billion)
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancers
· Tumor Ablation Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Tumor Ablation Market, By Country
o U.S. Tumor Ablation Market
o Canada Tumor Ablation Market
o Mexico Tumor Ablation Market
o Europe
§ Europe Tumor Ablation Market, By Country
o Germany Tumor Ablation Market
o UK Tumor Ablation Market
o France Tumor Ablation Market
o Russia Tumor Ablation Market
o Italy Tumor Ablation Market
o Rest of Europe Tumor Ablation Market
o Asia-Pacific
§ Asia-Pacific Tumor Ablation Market, By Country
o China Tumor Ablation Market
o Japan Tumor Ablation Market
o South Korea Tumor Ablation Market
o India Tumor Ablation Market
o Southeast Asia Tumor Ablation Market
o Rest of Asia-Pacific Tumor Ablation Market
o South America
§ South America Tumor Ablation Market
o Brazil Tumor Ablation Market
o Argentina Tumor Ablation Market
o Columbia Tumor Ablation Market
o South Africa Tumor Ablation Market
o Rest of South America Tumor Ablation Market
o Middle East and Africa
§ Middle East and Africa Tumor Ablation Market
o Saudi Arabia Tumor Ablation Market
o UAE Tumor Ablation Market
o Egypt Tumor Ablation Market
o Nigeria Tumor Ablation Market
o South Africa Tumor Ablation Market
o Rest of MEA Tumor Ablation Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Tumor Ablation Market, By Technology
5.1. Introduction
5.2. Global Tumor Ablation Sales, Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Tumor Ablation Sales and Sales Share by Technology (2017-2027)
5.2.2. Global Tumor Ablation Revenue and Revenue Share by Technology (2017-2027)
5.3. Radiofrequency
5.3.1. Global Radiofrequency Sales and Growth Rate (2017-2027)
5.4. Microwave ablation
5.4.1. Global Microwave ablation Sales and Growth Rate (2017-2027)
5.5. Cryoablation
5.5.1. Global Cryoablation Sales and Growth Rate (2017-2027)
5.6. Other ablation technologies
5.6.1. Global Other ablation technologies Sales and Growth Rate (2017-2027)
6. Tumor Ablation Market, By Treatment
6.1. Introduction
6.2. Global Tumor Ablation Sales, Revenue and Market Share by Treatment (2017-2027)
6.2.1. Global Tumor Ablation Sales and Sales Share by Treatment (2017-2027)
6.2.2. Global Tumor Ablation Revenue and Revenue Share by Treatment (2017-2027)
6.3. Surgical tumor ablation
6.3.1. Global Surgical tumor ablation Sales and Growth Rate (2017-2027)
6.4. Laparoscopic tumor ablation
6.4.1. Global Laparoscopic tumor ablation Sales and Growth Rate (2017-2027)
6.5. Percutaneous tumor ablation
6.5.1. Global Percutaneous tumor ablation Sales and Growth Rate (2017-2027)
7. Tumor Ablation Market, By Application
7.1. Introduction
7.2. Global Tumor Ablation Sales, Revenue and Market Share by Application (2017-2027)
7.2.1. Global Tumor Ablation Sales and Sales Share by Application (2017-2027)
7.2.2. Global Tumor Ablation Revenue and Revenue Share by Application (2017-2027)
7.3. Liver cancer
7.3.1. Global Liver cancer Sales and Growth Rate (2017-2027)
7.4. Breast cancer
7.4.1. Global Breast cancer Sales and Growth Rate (2017-2027)
7.5. Lung cancer
7.5.1. Global Lung cancer Sales and Growth Rate (2017-2027)
7.6. Prostate cancer
7.6.1. Global Prostrate cancer Sales and Growth Rate (2017-2027)
7.7. Other Cancers
7.7.1. Global Other cancers Sales and Growth Rate (2017-2027)
8. Tumor Ablation Market, By Region
8.1. Introduction
8.2. Global Tumor Ablation Sales, Revenue and Market Share by Regions
8.2.1. Global Tumor Ablation Sales by Regions (2017-2027)
8.2.2. Global Tumor Ablation Revenue by Regions (2017-2027)
8.3. North America Tumor Ablation by Countries
8.3.1. North America Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.2. North America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.3.3. North America Tumor Ablation Sales by Countries (2017-2027)
8.3.4. North America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.5.2. United States Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Tumor Ablation Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Tumor Ablation by Countries
8.4.1. Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.2. Europe Tumor Ablation Revenue and Growth Rate (2017-2027)
8.4.3. Europe Tumor Ablation Sales by Countries (2017-2027)
8.4.4. Europe Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.6.2. UK Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.7.2. France Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Tumor Ablation Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Tumor Ablation Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.5.2. China Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.8.2. India Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.2. South America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.6.3. South America Tumor Ablation Sales by Countries (2017-2027)
8.6.4. South America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Tumor Ablation Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Tumor Ablation Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Medtronic Plc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Angiodynamics
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Mermaid Medical
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. HealthTronics
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Galil Medical Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. EDAP TMS S.A.
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Boston Scientific Corporation
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Sonacare Medical
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Misonix, Inc.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
9.10. Neuwave Medical, Inc.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Sales, Revenue and Market Share
10. Global Tumor Ablation Market Competition, by Manufacturer
10.1. Global Tumor Ablation Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Tumor Ablation Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Tumor Ablation Price by Manufacturer (2017-2017)
10.4. Top 5 Tumor Ablation Manufacturer Market Share
10.5. Market Competition Trend
11. Tumor Ablation Market Forecast (2027-2023)
11.1. Global Tumor Ablation Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Tumor Ablation Market Forecast by Regions (2027-2023)
11.2.1. North America Tumor Ablation Market Forecast (2027-2023)
11.2.1.1. United States Tumor Ablation Market Forecast (2027-2023)
11.2.1.2. Canada Tumor Ablation Market Forecast (2027-2023)
11.2.1.3. Mexico Tumor Ablation Market Forecast (2027-2023)
11.2.2. Europe Tumor Ablation Market Forecast (2027-2023)
11.2.2.1. Germany Tumor Ablation Market Forecast (2027-2023)
11.2.2.2. United Kingdom Tumor Ablations Market Forecast (2027-2023)
11.2.2.3. France Tumor Ablation Market Forecast (2027-2023)
11.2.2.4. Russia Tumor Ablation Market Forecast (2027-2023)
11.2.2.5. Italy Tumor Ablation Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Tumor Ablation Market Forecast (2027-2023)
11.2.3. Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.3.1. China Tumor Ablation Market Forecast (2027-2023)
11.2.3.2. Japan Tumor Ablation Market Forecast (2027-2023)
11.2.3.3. Korea Tumor Ablation Market Forecast (2027-2023)
11.2.3.4. India Tumor Ablation Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Tumor Ablation Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.4. South America Tumor Ablation Market Forecast (2027-2023)
11.2.4.1. Brazil Tumor Ablation Market Forecast (2027-2023)
11.2.4.2. Argentina Tumor Ablation Market Forecast (2027-2023)
11.2.4.3. Columbia Tumor Ablation Market Forecast (2027-2023)
11.2.4.4. Rest of South America Tumor Ablation Market Forecast (2027-2023)
11.2.5. Middle East and Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Tumor Ablation Market Forecast (2027-2023)
11.2.5.2. UAE Tumor Ablation Market Forecast (2027-2023)
11.2.5.3. Egypt Tumor Ablation Market Forecast (2027-2023)
11.2.5.4. Nigeria Tumor Ablation Market Forecast (2027-2023)
11.2.5.5. South Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Tumor Ablation Market Forecast (2027-2023)
11.3. Tumor Ablation Market Forecast by Technology (2027-2023)
11.3.1. Global Tumor Ablation Sales Forecast by Technology (2027-2023)
11.3.2. Global Tumor Ablation Sales Market Share Forecast by Technology (2027-2023)
11.4. Tumor Ablation Market Forecast by Treatment (2027-2023)
11.4.1. Global Tumor Ablation Sales Forecast by Treatment (2027-2023)
11.4.2. Global Tumor Ablation Sales Market Share Forecast by Treatment (2027-2023)
11.5. Tumor Ablation Market Forecast by Application (2027-2023)
11.5.1. Global Tumor Ablation Sales Forecast by Application (2027-2023)
11.5.2. Global Tumor Ablation Sales Market Share Forecast by Application (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Tumor Ablation Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|